Cutting Edge Information, Jan 2010, Pages: 324
product?
- How will your early-stage diabetes compound fare in tomorrow's market?
- Is there room for your drug, too?
Uncover Anti-diabetes Market Threats and Opportunities
Equip your teams
Sheila Greco Associates, May 2011, Pages: 1
Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham, with operations
Business Insights, Jan 2005
Inject new strategies into your diabetes product pipeline and maximize product potential with a review of new and emerging drug classes.
Keep abreast of competitive developments in the diabetes
Decision Resources, Inc., April 2008, Pages: 40
are clamouring for value-for-money drugs.
Get the Answers You Need to Shape Your Strategy
-Biologics markets are evolving into a complex mix of brands, next-generation brands, biosimilars, and second-generation
Elsevier Science and Technology, May 2008, Pages: 340
for Graves? Disease
Anti-TNF therapy - modulation of hormone axes
Islet-cell transplantation
"Immune Intervention in Type 1 Diabetes: Realities of Today and Hopes for Tomorrow"
Asherson, Ronald.
Walker
